(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

LEVEMIR

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

LEVEMIR

ST13

US500000076468735

Class

5

Filing

76468735

Registration

2808088

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

40

Latest update

05/01/2024

Trademark type

Combined

Nice classes

5

Filing date

11/07/2002

Registration date

01/27/2004

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

04/25/2024

Last transaction

05/01/2024

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

Filing basis

Intent to use, Foreign priority

Drawing code

5

Owner type

65

Owner location

DK-2880 Bagsvaerd, DK

Examiner

DALIER,JOHN DAVID

Law office

L50

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

Novo Nordisk A/S

Representatives

Spencer Beall White & Case LLP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Anti-diabetic preparations

Publications

History of USPTO decisions and trademark events.

40 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

04/25/2024

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

04/25/2024

RNL2

REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)

04/25/2024

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

04/25/2024

PR89

POST REGISTRATION ACTION MAILED - SEC. 8 & 9

04/09/2024

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

04/09/2024

E89R

TEAS SECTION 8 & 9 RECEIVED

11/28/2023

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

01/27/2023

COC.

CORRECTION UNDER SECTION 7 - PROCESSED

10/18/2018

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

10/17/2018

ES7R

TEAS SECTION 7 REQUEST RECEIVED

10/01/2018

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

12/28/2013

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

12/28/2013

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

12/28/2013

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

12/28/2013

89AF

REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED

12/17/2013

E89R

TEAS SECTION 8 & 9 RECEIVED

12/17/2013

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

07/08/2013

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

07/08/2013

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

04/04/2011

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

04/04/2011

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

07/23/2010

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

07/23/2010

8.OK

REGISTERED - SEC. 8 (6-YR) ACCEPTED

02/04/2010

ES8R

TEAS SECTION 8 RECEIVED

01/27/2010

ES7R

TEAS SECTION 7 REQUEST RECEIVED

01/27/2010

COC.

CORRECTION UNDER SECTION 7 - PROCESSED

06/13/2008

PLGL

ASSIGNED TO PARALEGAL

06/09/2008

AMD7

SEC 7 REQUEST FILED

05/06/2008

MAIL

PAPER RECEIVED

05/06/2008

CFIT

CASE FILE IN TICRS

06/07/2007

R.PR

REGISTERED-PRINCIPAL REGISTER

01/27/2004

PUBO

PUBLISHED FOR OPPOSITION

11/04/2003

NPUB

NOTICE OF PUBLICATION

10/15/2003

1.BD

Sec. 1(B) CLAIM DELETED

07/24/2003

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

07/24/2003

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/16/2003

MAIL

PAPER RECEIVED

05/16/2003

CNRT

NON-FINAL ACTION MAILED

03/10/2003

DOCK

ASSIGNED TO EXAMINER

03/03/2003

Continuous trademark protection

Get notified about every new filing that threatens LEVEMIR or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.